78 assets in Depressive Disorder

Therapeutic assets addressing Depressive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Brexpiprazole Depressive Disorder	Dr. Albert Kar-Kin Chung	P4	A (82)
Jnj-54135419 Depressive Disorder	Chinese PLA General Hospital	P4	BBB (75)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Depressive Disorder	VA Office of Research and Development	P4	BBB (74)
Escitalopram Depressive Disorder	Poznan University of Medical Sciences	P4	BBB (74)
Fluoxetine Depressive Disorder	University of Oxford	P4	BBB (74)
Lithium, Elemental Depressive Disorder	Rakitzi, Stavroula	P4	BBB (74)
Paroxetine Depressive Disorder	Brigham and Women's Hospital	P4	BBB (74)
Sertraline Depressive Disorder	Tanta University	P4	BBB (73)
Amitriptyline Depressive Disorder	Zhejiang Cancer Hospital	P4	BBB (72)
Duloxetine Depressive Disorder	Huazhong University of Science and Technology	P4	BBB (72)
Naltrexone Depressive Disorder	King's College London	P4	BB (71)
Pregabalin Depressive Disorder	Zhejiang Cancer Hospital	P4	BB (71)
Quetiapine Depressive Disorder	Massachusetts General Hospital	P4	BB (71)
Vts-K Depressive Disorder	Theresa Jacob, PhD, MPH	P4	BB (69)
Cariprazine Depressive Disorder	Massachusetts General Hospital	P4	BB (68)
Teonanacatl Depressive Disorder	Yale University	P2	BB (68)
Melatonin Depressive Disorder	Massachusetts General Hospital	P4	BB (66)
Methylphenidate Depressive Disorder	University of California, San Francisco	P4	BB (66)
Risperidone Depressive Disorder	University of Chicago	P3	BB (66)
Propofol Depressive Disorder	Min Su	P4	BB (65)
Sertralin Depressive Disorder	Poznan University of Medical Sciences	P4	BB (65)
Dinitrogen Monoxide Depressive Disorder	Lingjiang Li	P2	BB (64)
Metformin Depressive Disorder	Riphah International University	P4	B (63)
Pramipexole Depressive Disorder	University of California, San Francisco	P4	B (63)
Trazodone Depressive Disorder	Centre Hospitalier St Anne	P3	B (63)
Vortioxetine Depressive Disorder	H. Lundbeck A/S	P4	B (63)
Agomelatine Depressive Disorder	First Affiliated Hospital, Sun Yat-Sen University	P4	B (62)
Buspirone Depressive Disorder	Massachusetts General Hospital	P4	B (62)
Nepenthe Depressive Disorder	Istituti Clinici Scientifici Maugeri SpA	P4	B (62)
Onfasprodil Depressive Disorder	Novartis Pharmaceuticals	P2	B (62)
Midazolam Depressive Disorder	Federal University of São Paulo	P3	B (61)
JS1-1-01 Depressive Disorder	Tasly Pharmaceutical Group Co., Ltd	P2/3	B (60)
Lumateperone Depressive Disorder	Eric Lenze	P3	B (60)
Oxycodone Depressive Disorder	The Second Hospital of Anhui Medical University	P4	B (60)
cyb003 Depressive Disorder	Cybin IRL Limited	P3	B (59)
Lurasidone Depressive Disorder	Massachusetts General Hospital	P4	B (59)
Progesterone Depressive Disorder	University of North Carolina, Chapel Hill	P4	B (59)
(S)-3,5-Dichloro-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-6-Hydroxy-O-Anisamide Depressive Disorder	University of North Carolina, Chapel Hill	P4	B (59)
Clozapine Depressive Disorder	Rakitzi, Stavroula	P3	B (58)
Atorvastatin Depressive Disorder	Tanta University	P2	B (57)
Dapagliflozin Depressive Disorder	Tanta University	P2	B (57)
N,N-Dimethyltryptamine Depressive Disorder	Universidade Federal do Rio Grande do Norte	P2	B (57)
Phenelzine Depressive Disorder	University of California, San Francisco	P4	B (57)
Flortaucipir Depressive Disorder	Washington University School of Medicine	P2	CCC (54)
Rel-1017 Depressive Disorder	Levomecor Inc.	P3	CCC (54)
Tnx-601 Er Depressive Disorder	Tonix Pharmaceuticals, Inc.	P2	CCC (54)
Acp-211 Depressive Disorder	ACADIA Pharmaceuticals Inc.	P2	CCC (53)
ci-581a Depressive Disorder	New York State Psychiatric Institute	P2	CCC (53)
ci-581b Depressive Disorder	New York State Psychiatric Institute	P2	CCC (53)
Perampanel Depressive Disorder	Yale University	P2	CCC (53)

Showing 1 to 50 of 78 assets

PreviousPage 1 of 2Next